Case Series: Tattoo-associated Uveitis
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2022/01/10
-
Journal
-
Indian UGC (journal)
-
Refrences17
-
Citations1
-
Aaron S. Peterson
-
Anthony W. Patterson
Abstract
Cite
Peterson, Aaron S., and Anthony W. Patterson. “Case Series: Tattoo-Associated Uveitis”. Optometry and Vision Science, vol. 99, no. 4, 2022, pp. 383-8, https://doi.org/10.1097/opx.0000000000001859.
Peterson, A. S., & Patterson, A. W. (2022). Case Series: Tattoo-associated Uveitis. Optometry and Vision Science, 99(4), 383-388. https://doi.org/10.1097/opx.0000000000001859
Peterson, Aaron S., and Anthony W. Patterson. “Case Series: Tattoo-Associated Uveitis”. Optometry and Vision Science 99, no. 4 (2022): 383-88. https://doi.org/10.1097/opx.0000000000001859.
Peterson AS, Patterson AW. Case Series: Tattoo-associated Uveitis. Optometry and Vision Science. 2022;99(4):383-8.
Journal Categories
Medicine
Medicine (General)
Medicine
Ophthalmology
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Tattoo-associated panuveitis: A 10-year follow-up | European Journal of Ophthalmology |
| 4 | 2019 |
Tattoo‐associated uveitis with or without systemic sarcoidosis: a comparative review of the literature | Journal of the European Academy of Dermatology and Venereology |
| 37 | 2018 |
| T-Lymphocyte Predominance and Cellular Atypia in Tattoo-Associated Uveitis | JAMA Ophthalmology |
| 9 | 2015 |
| Sarcoidosis | 2014 | |||
| Tattoo-Associated Uveitis | American Journal of Ophthalmology |
| 47 | 2014 |
Refrences Analysis
| Category | Category Repetition |
|---|---|
| Medicine: Medicine (General) | 12 |
| Medicine | 4 |
| Medicine: Ophthalmology | 4 |
| Medicine: Internal medicine | 2 |
| Medicine: Dermatology | 2 |
The category
Medicine: Medicine (General) 12
is the most frequently represented among the references in this article. It primarily includes studies from American Journal of Ophthalmology and Wiener klinische Wochenschrift. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Janus kinase inhibitor Abrocitinib as an Off‐Label treatment for tattoo granuloma with uveitis (TAGU) | Australasian Journal of Dermatology |
| 2024 |
Citations Analysis
| Category | Category Repetition |
|---|---|
| Medicine: Medicine (General) | 1 |
| Medicine: Dermatology | 1 |
The category
Medicine: Medicine (General) 1
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Janus kinase inhibitor Abrocitinib as an Off‐Label treatment for tattoo granuloma with uveitis (TAGU) and was published in 2024. The most recent citation comes from a 2024 study titled Janus kinase inhibitor Abrocitinib as an Off‐Label treatment for tattoo granuloma with uveitis (TAGU). This article reached its peak citation in 2024, with 1 citations. It has been cited in 1 different journals. Among related journals, the Australasian Journal of Dermatology cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.